Macrocyclic inhibitors of hepatitis c virus ns3 serine protease

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 5/06 (2006.01) A61P 31/22 (2006.01)

Patent

CA 2701787

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such com- pounds as well as methods of using them to treat disorders associated with the HCV protease.

L'invention concerne de nouveaux composés qui possèdent une activité inhibitrice de la protéase du virus de l'hépatite C ainsi que des procédés pour préparer de tels composés. Dans un autre mode de réalisation, l'invention décrit des compositions pharmaceutiques comprenant de tels composés ainsi que des procédés les utilisant pour traiter des troubles associés à la protéase du virus de l'hépatite C.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Macrocyclic inhibitors of hepatitis c virus ns3 serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic inhibitors of hepatitis c virus ns3 serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic inhibitors of hepatitis c virus ns3 serine protease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1818001

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.